Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Comparing Copy Number Variations and SNPs02:26

Comparing Copy Number Variations and SNPs

18.4K
Sequencing of the human genome has opened up several best-kept secrets of the genome. Scientists have identified thousands of genome variations that exist within a population. These variations can be a single nucleotide or a larger chromosomal variation.
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
18.4K
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

423
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
423
Multiple Comparison Tests01:13

Multiple Comparison Tests

4.3K
Multiple comparison test, abbreviated as MCT, is a post hoc analysis generally performed after comparing multiple samples with one or more tests. An MCT will help identify a significantly different sample among multiple samples or a factor among multiple factors.
It would be easy to compare two samples using a significance alpha level of 0.05. In other words, there is only one sample pair to be compared. However, it would be difficult to identify a significantly different sample if the number...
4.3K
One-Way ANOVA: Equal Sample Sizes01:15

One-Way ANOVA: Equal Sample Sizes

3.8K
One-Way ANOVA can be performed on three or more samples with equal or unequal sample sizes. When one-way ANOVA is performed on two datasets with samples of equal sizes, it can be easily observed that the computed F statistic is highly sensitive to the sample mean.
Different sample means can result in different values for the variance estimate: variance between samples. This is because the variance between samples is calculated as the product of the sample size and the variance between the...
3.8K
One-Way ANOVA: Unequal Sample Sizes01:15

One-Way ANOVA: Unequal Sample Sizes

6.4K
One-way ANOVA can be performed on three or more samples of unequal sizes. However, calculations get complicated when sample sizes are not always the same. So, while performing ANOVA with unequal samples size, the following equation is used:
6.4K
Wilcoxon Signed-Ranks Test for Median of Single Population01:14

Wilcoxon Signed-Ranks Test for Median of Single Population

339
The Wilcoxon signed-rank test for the median of a single population is a nonparametric test used to evaluate whether the median of a population differs from a specified value. Unlike parametric tests, it does not require data to follow a normal distribution, making it suitable for non-normal or small samples. The test begins by calculating the difference (d) between each observation and the hypothesized median. The absolute values of these differences are ranked in ascending order, with ties...
339

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Phage-guided rapid enrichment of copper-protocatechuic acid nanoparticles for targeted antibacterial therapy.

Journal of nanobiotechnology·2026
Same author

A transgenic rotifer-based RNA interference approach for antiviral protection against <i>Covert mortality nodavirus</i> in shrimp aquaculture.

Frontiers in microbiology·2026
Same author

Temporal-Spatial Differences of Nitrogen Source-Sink in Sediments of Wetland-River Connected System and Response Mechanism of Microbial Community Function.

Microorganisms·2026
Same author

Pancancer pro-angiogenic atlas unravels tumor-educated pericyte-augmented anti-angiogenic resistance.

Science bulletin·2026
Same author

Bacitracin-regulated injectable PHEMA hydrogels with intrinsic mild negative swelling for soft tissue repair.

Materials horizons·2026
Same author

Advances in PD-L1 Targeted Molecular Imaging Radiotracers Research: From Preclinical Exploration to Clinical Application.

Molecular imaging and biology·2026

Related Experiment Video

Updated: Nov 29, 2025

Three Differential Expression Analysis Methods for RNA Sequencing: limma, EdgeR, DESeq2
10:10

Three Differential Expression Analysis Methods for RNA Sequencing: limma, EdgeR, DESeq2

Published on: September 18, 2021

40.0K

MAnorm2 for quantitatively comparing groups of ChIP-seq samples.

Shiqi Tu1,2, Mushan Li1, Haojie Chen1,2

  • 1CAS Key Laboratory of Computational Biology, CAS-MPG Partner Institute for Computational Biology, Shanghai Institute of Nutrition and Health, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai 200031, China.

Genome Research
|November 19, 2020
PubMed
Summary
This summary is machine-generated.

MAnorm2 is a new computational tool that quantitatively compares ChIP-seq samples. It outperforms existing methods for differential ChIP-seq analysis, especially when sample groups have varying variability.

More Related Videos

Mapping the Structure-Function Relationships of Disordered Oncogenic Transcription Factors Using Transcriptomic Analysis
09:58

Mapping the Structure-Function Relationships of Disordered Oncogenic Transcription Factors Using Transcriptomic Analysis

Published on: June 27, 2020

3.0K
A New Approach for the Comparative Analysis of Multiprotein Complexes Based on 15N Metabolic Labeling and Quantitative Mass Spectrometry
08:04

A New Approach for the Comparative Analysis of Multiprotein Complexes Based on 15N Metabolic Labeling and Quantitative Mass Spectrometry

Published on: March 13, 2014

12.5K

Related Experiment Videos

Last Updated: Nov 29, 2025

Three Differential Expression Analysis Methods for RNA Sequencing: limma, EdgeR, DESeq2
10:10

Three Differential Expression Analysis Methods for RNA Sequencing: limma, EdgeR, DESeq2

Published on: September 18, 2021

40.0K
Mapping the Structure-Function Relationships of Disordered Oncogenic Transcription Factors Using Transcriptomic Analysis
09:58

Mapping the Structure-Function Relationships of Disordered Oncogenic Transcription Factors Using Transcriptomic Analysis

Published on: June 27, 2020

3.0K
A New Approach for the Comparative Analysis of Multiprotein Complexes Based on 15N Metabolic Labeling and Quantitative Mass Spectrometry
08:04

A New Approach for the Comparative Analysis of Multiprotein Complexes Based on 15N Metabolic Labeling and Quantitative Mass Spectrometry

Published on: March 13, 2014

12.5K

Area of Science:

  • Genomics
  • Molecular Biology
  • Bioinformatics

Background:

  • Eukaryotic gene transcription relies on chromatin-associated proteins.
  • Comparing ChIP-seq data is crucial for understanding differential protein binding sites across cellular contexts.
  • Existing tools face challenges in analyzing ChIP-seq data with diverse within-group variability.

Purpose of the Study:

  • To introduce MAnorm2, a novel computational tool for quantitative comparison of ChIP-seq sample groups.
  • To provide a robust method for differential ChIP-seq analysis that accounts for varying within-group variability.

Main Methods:

  • MAnorm2 employs a hierarchical normalization strategy for ChIP-seq data.
  • It utilizes an empirical Bayes framework to assess within-group variability.
  • The tool is designed to handle significant differences in global within-group variability between sample groups.

Main Results:

  • MAnorm2 demonstrated superior performance compared to existing tools in differential ChIP-seq analysis.
  • The tool's effectiveness was particularly evident when analyzing datasets with distinct global within-group variability.
  • Real ChIP-seq datasets confirmed MAnorm2's enhanced accuracy and reliability.

Conclusions:

  • MAnorm2 offers a significant advancement in the analysis of differential ChIP-seq data.
  • The tool provides a more accurate and robust method for identifying differential binding sites.
  • MAnorm2 is particularly valuable for studies involving complex biological systems with inherent data variability.